AAAAAA
Results: 26-32/32
Authors:
KINSCHERF R
FISCHBACH T
MIHM S
ROTH S
HOHENHAUSSIEVERT E
WEISS C
EDLER L
BARTSCH P
DROGE W
Citation: R. Kinscherf et al., EFFECT OF GLUTATHIONE DEPLETION AND ORAL N-ACETYL-CYSTEINE TREATMENT ON CD4(+) AND CD8(+) CELLS, The FASEB journal, 8(6), 1994, pp. 448-451
Authors:
HERRMANN R
MANEGOLD C
BREMER K
BECHER R
KRIEGBAUM H
EDLER L
QUEISSER W
Citation: R. Herrmann et al., ILMOFOSINE (BM-41.440) IN RENAL-CELL CANCER - A MULTICENTER PHASE-II STUDY, Onkologie, 17(3), 1994, pp. 278-279
Authors:
JUNG D
KONIETZKO J
REILLKONIETZKO G
MUTTRAY A
ZIMMERMANNHOLZ HJ
DOSS M
BECK H
EDLER L
KOPPSCHNEIDER A
Citation: D. Jung et al., PORPHYRIN STUDIES IN TCDD-EXPOSED WORKERS, Archives of toxicology, 68(9), 1994, pp. 595-598
Authors:
EDLER L
Citation: L. Edler, BIOSTATISTICAL ISSUES IN THE DESIGN AND ANALYSIS OF MULTIPLE OR REPEATED GENOTOXICITY ASSAYS, Environmental health perspectives, 102, 1994, pp. 53-59
Authors:
PORTIER CJ
LUCIER GW
EDLER L
Citation: Cj. Portier et al., RISK FROM LOW-DOSE EXPOSURES, Science, 266(5188), 1994, pp. 1141-1142
Authors:
UNGER C
BECHER R
RIECHE K
WANDER HE
FRIEDRICH G
EDLER L
Citation: C. Unger et al., DAILY ORAL MILTEFOSINE (HEXADECYLPHOSPHOCHOLINE) IN PATIENTS WITH ADVANCED BREAST-CANCER - A PHASE-II STUDY, Onkologie, 16(4), 1993, pp. 260-263
Authors:
UNGER C
HERRMANN R
BERDEL WE
KLEEBERG UR
GATZEMEIER U
ILLIGER HJ
WANDER HE
WESTERHAUSEN M
BECHER R
BREMER K
RIECHE K
ESSERS U
QUEISSER W
HEIDEMANN E
FIEBIG HH
POSSINGER K
JOURDAINMADL B
HEIM ME
EDLER L
Citation: C. Unger et al., TOPICALLY APPLIED MILTEFOSINE (HEXADECYLPHOSPHOCHOLINE) IN PATIENTS WITH SKIN-METASTASIZED BREAST-CANCER - A PHASE-II STUDY, Onkologie, 16(3), 1993, pp. 170-173